We are expanding the range of assay techniques that will allow us to understand the sulfation code in chondroitin sulfate glycosaminoglycan (CS-GAG) chains. These assay techniques take advantage of specific chromatography techniques (ion exchange, hydrophilicity) to separate the different disaccharides and monosaccharides that comprise the GAG chains. This is the only technique capable of doing this. We have also initiated mass spectrometric analysis of these separated GAG chains to begin to determine the sequence of sulfations on the different parts of the GAG chain. Our results indicate that the sulfation pattern of the non-reducing end of the GAG chain is a major determinant of CS signaling. A publication describing these results is in preparation. We published a systems biology study to understand CSPG signaling in cells. We identified a number of proteins whose phosphorylation is changed rapidly as neurons are exposed to CSPGs. Our results indicate that there are a number of different signaling pathways inovlved in response to CSPGs in cells, but that the changes in phosphorylations are modest. These results suggest that CSPG may modulate many difference cellular functions. We are conducting studies showing that the the LAR family of receptor protein tyrosine phosphatases are are binding partners for CS GAG chains. The binding of the different family members are not all the same. We have identified different regions in the extracellular domains of these molecules that bind GAG chains with different sulfation patterns. In addition our data point to an additional receptor that binds bioactive CSPGs. A publication describing these results is in preparation.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2013
Total Cost
$689,784
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Jin, Jingyu; Tilve, Sharada; Huang, Zhonghai et al. (2018) Effect of chondroitin sulfate proteoglycans on neuronal cell adhesion, spreading and neurite growth in culture. Neural Regen Res 13:289-297
Katagiri, Yasuhiro; Morgan, Ashlea A; Yu, Panpan et al. (2018) Identification of novel binding sites for heparin in receptor protein-tyrosine phosphatase (RPTP?): Implications for proteoglycan signaling. J Biol Chem 293:11639-11647
Yu, Panpan; Pearson, Craig S; Geller, Herbert M (2018) Flexible Roles for Proteoglycan Sulfation and Receptor Signaling. Trends Neurosci 41:47-61
Yi, Mengni; Wei, Tianjiao; Wang, Yanxia et al. (2017) The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke. J Neuroinflammation 14:203
Shumakovich, Marina A; Mencio, Caitlin P; Siglin, Jonathan S et al. (2017) Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells. FASEB J :
Yi, Mengni; Yu, Panpan; Lu, Qin et al. (2016) KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease. Mol Cell Neurosci 76:21-32
Janecke, Andreas R; Li, Ben; Boehm, Manfred et al. (2016) The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. Am J Med Genet A 170A:103-15
Polackwich, Robert J; Koch, Daniel; McAllister, Ryan et al. (2015) Traction force and tension fluctuations in growing axons. Front Cell Neurosci 9:417
Yu, Panpan; Agbaegbu, Chinyere; Malide, Daniela A et al. (2015) Cooperative interactions of LPPR family members in membrane localization and alteration of cellular morphology. J Cell Sci 128:3210-22
Yu, Zhihua; Yu, Panpan; Chen, Hongzhuan et al. (2014) Targeted inhibition of KCa3.1 attenuates TGF-?-induced reactive astrogliosis through the Smad2/3 signaling pathway. J Neurochem 130:41-49

Showing the most recent 10 out of 25 publications